In the case of potential therapy for neurodegenerative diseases, GDNF has a relatively high specificity for dopaminergic neurons and, thus, has significant potential for the treatment of PD, which is mainly characterized by progressive depletion of dopaminergic cell populations in the midbrain [79]. This evidence concerns the gene GDNF and Parkinson disease.